143 related articles for article (PubMed ID: 3950582)
1. Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice.
Gould EA; Buckley A; Barrett AD; Cammack N
J Gen Virol; 1986 Mar; 67 ( Pt 3)():591-5. PubMed ID: 3950582
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
Schlesinger JJ; Chapman S
J Gen Virol; 1995 Jan; 76 ( Pt 1)():217-20. PubMed ID: 7844536
[TBL] [Abstract][Full Text] [Related]
3. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
[TBL] [Abstract][Full Text] [Related]
4. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.
Gould EA; Buckley A; Cammack N; Barrett AD; Clegg JC; Ishak R; Varma MG
J Gen Virol; 1985 Jul; 66 ( Pt 7)():1369-82. PubMed ID: 2410549
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies.
Buckley A; Gould EA
J Gen Virol; 1985 Dec; 66 ( Pt 12)():2523-31. PubMed ID: 2999305
[TBL] [Abstract][Full Text] [Related]
6. Antibody-mediated early death in vivo after infection with yellow fever virus.
Barrett AD; Gould EA
J Gen Virol; 1986 Nov; 67 ( Pt 11)():2539-42. PubMed ID: 3783130
[TBL] [Abstract][Full Text] [Related]
7. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.
Schlesinger JJ; Brandriss MW; Walsh EE
J Immunol; 1985 Oct; 135(4):2805-9. PubMed ID: 4031501
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.
Schlesinger JJ; Brandriss MW; Monath TP
Virology; 1983 Feb; 125(1):8-17. PubMed ID: 6187129
[TBL] [Abstract][Full Text] [Related]
9. Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence.
Gould EA; Buckley A
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1605-8. PubMed ID: 2543793
[TBL] [Abstract][Full Text] [Related]
10. Yellow fever monoclonal antibodies: type-specific and cross-reactive determinants identified by immunofluorescence.
Monath TP; Schlesinger JJ; Brandriss MW; Cropp CB; Prange WC
Am J Trop Med Hyg; 1984 Jul; 33(4):695-8. PubMed ID: 6206738
[TBL] [Abstract][Full Text] [Related]
11. A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease.
Calvert AE; Dixon KL; Piper J; Bennett SL; Thibodeaux BA; Barrett AD; Roehrig JT; Blair CD
Antiviral Res; 2016 Jul; 131():92-9. PubMed ID: 27126613
[TBL] [Abstract][Full Text] [Related]
12. Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay.
Adungo F; Yu F; Kamau D; Inoue S; Hayasaka D; Posadas-Herrera G; Sang R; Mwau M; Morita K
Clin Vaccine Immunol; 2016 Aug; 23(8):689-97. PubMed ID: 27307452
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of wild-type yellow fever virus by passage in HeLa cells.
Barrett AD; Monath TP; Cropp CB; Adkins JA; Ledger TN; Gould EA; Schlesinger JJ; Kinney RM; Trent DW
J Gen Virol; 1990 Oct; 71 ( Pt 10)():2301-6. PubMed ID: 2230735
[TBL] [Abstract][Full Text] [Related]
14. Reduction of yellow fever virus mouse neurovirulence by immunization with a bacterially synthesized non-structural protein (NS1) fragment.
Cane PA; Gould EA
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1241-6. PubMed ID: 3133449
[TBL] [Abstract][Full Text] [Related]
15. Structure-Function of the Yellow Fever Virus Envelope Protein: Analysis of Antibody Epitopes.
Davis EH; Barrett ADT
Viral Immunol; 2020; 33(1):12-21. PubMed ID: 31682201
[TBL] [Abstract][Full Text] [Related]
16. CD8+ T cells complement antibodies in protecting against yellow fever virus.
Bassi MR; Kongsgaard M; Steffensen MA; Fenger C; Rasmussen M; Skjødt K; Finsen B; Stryhn A; Buus S; Christensen JP; Thomsen AR
J Immunol; 2015 Feb; 194(3):1141-53. PubMed ID: 25539816
[TBL] [Abstract][Full Text] [Related]
17. Plant-Produced Subunit Vaccine Candidates against Yellow Fever Induce Virus Neutralizing Antibodies and Confer Protection against Viral Challenge in Animal Models.
Tottey S; Shoji Y; Jones RM; Chichester JA; Green BJ; Musiychuk K; Si H; Manceva SD; Rhee A; Shamloul M; Norikane J; Guimarães RC; Caride E; Silva ANMR; Simões M; Neves PCC; Marchevsky R; Freire MS; Streatfield SJ; Yusibov V
Am J Trop Med Hyg; 2018 Feb; 98(2):420-431. PubMed ID: 29231157
[TBL] [Abstract][Full Text] [Related]
18. Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model.
Julander JG; Trent DW; Monath TP
Vaccine; 2011 Aug; 29(35):6008-16. PubMed ID: 21718741
[TBL] [Abstract][Full Text] [Related]
19. Analysis of 17D yellow fever virus envelope protein epitopes using monoclonal antibodies.
Schlesinger JJ; Walsh EE; Brandriss MW
J Gen Virol; 1984 Oct; 65 ( Pt 10)():1637-44. PubMed ID: 6208313
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a purified fragment of 17D yellow fever envelope protein.
Brandriss MW; Schlesinger JJ; Walsh EE
J Infect Dis; 1990 Jun; 161(6):1134-9. PubMed ID: 1693159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
